Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-08-12

FDA Approved: PROPOFOL — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved Hospira's supplemental application for Propofol for use as an anesthetic/sedative agent.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROPOFOL (Propofol)

Snippet

SUPPL AP for PROPOFOL (PROPOFOL)